se ha leído el artículo
array:22 [ "pii" => "S0001731024007208" "issn" => "00017310" "doi" => "10.1016/j.ad.2024.07.020" "estado" => "S200" "fechaPublicacion" => "2024-10-08" "aid" => "4074" "copyright" => "AEDV" "copyrightAnyo" => "2024" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:17 [ "pii" => "S0001731024005313" "issn" => "00017310" "doi" => "10.1016/j.ad.2024.03.036" "estado" => "S200" "fechaPublicacion" => "2024-10-04" "aid" => "4003" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "crp" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>" "titulo" => "Disseminated Cutaneous Lesions in an Immunocompromised Patient: A Diagnostic Challenge" "tienePdf" => "en" "tieneTextoCompleto" => "en" "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Lesiones cutáneas diseminadas en una paciente inmunocomprometida: un reto diagnóstico" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1767 "Ancho" => 2557 "Tamanyo" => 894267 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Brownish erythematous plaques on the face (A). Violaceous plaques on left forearm and arm (B). Nodules and a large erythematous infiltrated plaque on the posterior lower left leg with areas of ulceration (C). Positive Gomori structures within histiocytes (Gomori staining, 40×). (D) Granulomatous nodular inflammatory process consisting of lymphocytes, histiocytes, and some plasma cells in the upper and deep dermis (H&E staining, 10×). (E) <span class="elsevierStyleItalic">Leishmania</span> amastigote, arrow (H&E staining, 600×). (F) Anti-CD68 (clone KP1) immunohistochemistry showing intense cytoplasmic positivity in macrophages. In addition, some amastigotes can be observed, arrows (IHQ, 600×) (G).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "P.M. Guavita Falla, B. Rodríguez Lechtig, E. Peñaranda Contreras, C. Cortés Correa" "autores" => array:4 [ 0 => array:2 [ "nombre" => "P.M." "apellidos" => "Guavita Falla" ] 1 => array:2 [ "nombre" => "B." "apellidos" => "Rodríguez Lechtig" ] 2 => array:2 [ "nombre" => "E." "apellidos" => "Peñaranda Contreras" ] 3 => array:2 [ "nombre" => "C." "apellidos" => "Cortés Correa" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731024005313?idApp=UINPBA000044" "url" => "/00017310/unassign/S0001731024005313/v2_202410091022/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "S0001731023004908" "issn" => "00017310" "doi" => "10.1016/j.ad.2023.05.022" "estado" => "S200" "fechaPublicacion" => "2023-07-18" "aid" => "3547" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "crp" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>" "titulo" => "Recalcitrant Hailey–Hailey Disease With Satisfactory Response to Apremilast" "tienePdf" => "en" "tieneTextoCompleto" => "en" "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Enfermedad de Hailey-Hailey recalcitrante con respuesta satisfactoria a apremilast" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2049 "Ancho" => 1555 "Tamanyo" => 362161 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Red-brown plaques with superficial erosions and a macerated appearance, located in the axillary folds (A) and groin (B) before the start of treatment with apremilast. Note the improvement of the lesions after 6 months of treatment with apremilast 30<span class="elsevierStyleHsp" style=""></span>mg twice a day (C and D).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Mansilla-Polo, C. Abril-Pérez, M.Á. Navarro-Mira, R. Botella-Estrada" "autores" => array:4 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Mansilla-Polo" ] 1 => array:2 [ "nombre" => "C." "apellidos" => "Abril-Pérez" ] 2 => array:2 [ "nombre" => "M.Á." "apellidos" => "Navarro-Mira" ] 3 => array:2 [ "nombre" => "R." "apellidos" => "Botella-Estrada" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731023004908?idApp=UINPBA000044" "url" => "/00017310/unassign/S0001731023004908/v1_202307180913/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Comment on “MPOX (Formerly Monkeypox): Review on the Most Relevant Clinical, Epidemiological, Diagnostic and Therapeutic Aspects for the Dermatologist”" "tieneTextoCompleto" => true "saludo" => "To the Editor:" "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Y.S. Pathania" "autores" => array:1 [ 0 => array:3 [ "nombre" => "Y.S." "apellidos" => "Pathania" "email" => array:1 [ 0 => "yashdeepsinghpathania@gmail.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of Dermatology, Venereology and Leprology, All India Institute of Medical Sciences, Rajkot, Gujarat, India" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Comentario en “MPOX (antes viruela simica): revisión de los aspectos clínicos, epidemiológicos, diagnósticos y terapéuticos más relevantes para el dermatólogo”" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We read the quite enlightening article ‘MPOX (formerly monkeypox): review of the most relevant clinical, epidemiological, diagnostic and therapeutic aspects for the dermatologist’ by Catala et al. with great interest.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a> The global outbreak of monkeypox has led to more than 15,000 cases being reported in non-endemic countries. This article is an addendum to the article published by the authors to differentiate similar looking lesions described in monkeypox, chickenpox, and COVID 19 for which literature is scarce. The World Health Organization (WHO) has recommended the use of the term ‘MPOX’—as opposed to monkeypox—to avoid the stigma associated with the term. It has also been reported in the United States in patients traveling from the endemic central and West Africa. In the absence of a history of travel to endemic countries, cases are being frequently seen in men who have sex with men (MSM).<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Monkeypox is a double stranded DNA virus of the poxviridae family. Respiratory droplets, fomites and direct contact are the main routes of transmission. The definition of a monkeypox case has been defined by the U.S. Centers for Disease Control and Prevention (CDC) (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). The incubation period lasts between 5 and 21 days. Cases of monkeypox usually present as fever, rash and lymphadenopathy. Monkeypox rash is a monomorphic painful vesiculopustular lesion with early central umbilication and a prominent white rim surrounded by an erythematous halo over the face, extremities, trunk, genitals, palms and soles. It is imperative to differentiate the current Monkeypox outbreak from the pandemic of coronavirus disease 2019 (COVID-19).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">The prevalence of papulovesicular rash in COVID-19 is 3.7% up to 15%.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">3</span></a> Two morphological patterns have emerged in COVID-19 vesicular exanthem: localized and a more common, widespread polymorphic pattern consisting of small papules, vesicles and pustules. Vesicular rash appears 3 days after the onset of systemic symptoms and disappears 8 days later, which suggests an earlier resolution than monkeypox rash.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">4</span></a> Moreover, vesicular exanthem in COVID-19 is characterized by small size, a frequently compromised trunk, and mild or absent pruritus while the monkeypox exanthem is characterized by painful, monomorphic, large size lesions, frequently involving the face, extremities, genitals, palms and soles. Several studies have confirmed the transmission of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) through semen whereas no outbreaks of monkeypox in men who have sex with men (MSM) have ever been reported. However, the semen or vaginal fluid route of transmission is yet to be elucidated.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">5</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Chickenpox rash tends to develop more rapidly than monkeypox and each lesion is less severe, less painful or not painful at all, and commonly associated with pruritus and evolving pleomorphically in a centripetal pattern compared with monkeypox rash, which exhibits monomorphic painful lesions evolving in a centrifugal pattern. Bilateral presentation in monkeypox is different from that of herpes zoster.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Diagnostic confirmation of monkeypox requires a positive lesion-based monkeypox-specific polymerase chain reaction assay. Broncho-pneumonia, encephalitis, ocular infections and sepsis are the most common complications of monkeypox disease, which has a self-limiting course within a matter of 2–4 weeks. Oral antivirals developed for smallpox such as brincidofovir and tecovirimat are available to treat monkeypox especially in immunocompromised patients. Smallpox vaccines have shown a 85% efficacy rate to prevent monkeypox.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">6</span></a> Similar vaccines may be used for post-exposure prophylaxis (PEP) if administered within a 96-h timeframe after exposure.</p><p id="par0030" class="elsevierStylePara elsevierViewall">The dissemination of monkeypox in non-endemic countries means changes have occurred in the typical pattern of this disease, as well as a changing epidemiology. Of note the recent monkeypox outbreaks described in the context of the current COVID-19 pandemic, as well as the need to clinically recognize the disease early in a resource-poor settings. Further studies are required to understand whether the current monkeypox outbreak is an independent phenomenon or has been exacerbated by the COVID-19 pandemic.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Funding source</span><p id="par0035" class="elsevierStylePara elsevierViewall">None.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Authors’ contributions</span><p id="par0040" class="elsevierStylePara elsevierViewall">Y.S. Pathania – Prepared and finalized the manuscript.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Conflict of interest</span><p id="par0045" class="elsevierStylePara elsevierViewall">None.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Data availability statement</span><p id="par0050" class="elsevierStylePara elsevierViewall">No new data were generated or analyzed in support of this research.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Funding source" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Authors’ contributions" ] 2 => array:2 [ "identificador" => "sec0015" "titulo" => "Conflict of interest" ] 3 => array:2 [ "identificador" => "sec0020" "titulo" => "Data availability statement" ] 4 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleBold">Suspected case</span> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">New characteristic rash (as explained above) OR meets 1 epidemiologic criteria and has a high clinical suspicion</span><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">c</span></a><span class="elsevierStyleItalic">for monkeypox</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Epidemiological criteria</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Within 21 days of disease onset:</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>• Reports having had contact with a person or people with a similar appearing rash or who were diagnosed or had diagnostic confirmation of monkeypox or probable monkeypox OR<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>• Had close or intimate personal contact with individuals from a social network experiencing monkeypox activity, including men who have sex with men (MSM) who meet partners through online websites, digital applications (“app”), or social events (e.g., a bar or party) OR<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>• Traveled outside the United States to a country with confirmed cases of monkeypox or where monkeypox virus is endemic OR<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>• Had contact with a dead or live wild animal or exotic pet that is an African endemic species or used a product derived from such animals (e.g., game meat, creams, lotions, powders, etc.) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleBold">Probable case:</span> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">No suspicion of other recent orthopoxvirus exposure (e.g., vaccinia virus in ACAM2000 vaccination) AND confirmation of the presence of</span><a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>• Orthopoxvirus DNA by PCR of a clinical specimen OR<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>• Orthopoxvirus using immunohistochemical or electron microscopy testing methods OR<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>• Demonstration of detectable levels of anti-orthopoxvirus IgM antibody 4–56 days after rash onset \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleBold">Exclusion criteria:</span> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">A case may be excluded as a suspect, probable, or confirmed case if:</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>• An alternate diagnosis can fully explain the illness OR<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>• An individual with symptoms consistent with monkeypox does not develop any rashes within 5 days of disease onset OR<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>• A case in which high-quality specimens do not confirm the presence of orthopoxvirus or monkeypox virus or antibodies to orthopoxvirus \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3683503.png" ] ] ] "notaPie" => array:3 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Antibody and antigen detection methods are not confirmatory since orthopox viruses show serological cross-125 reactivity.</p>" ] 1 => array:3 [ "identificador" => "tblfn0015" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Monkeypox endemic countries: Benin, Cameroon, the Central African Republic, the Democratic Republic of the Congo, Gabon, Ghana (identified in animals only), Côte d’Ivoire, Liberia, Nigeria, the Republic of the Congo, and Sierra Leone. Benin and South Sudan have documented importations in the past. Countries currently reporting cases of the West African clade are Cameroon and Nigeria.</p>" ] 2 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "c" "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Clinical suspicion can exist if initial signs and symptoms are consistent with diseases confused with monkeypox 122 (e.g., secondary syphilis, herpes, and varicella zoster).</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">CDC case definitions for the current monkeypox outbreak in non-endemic<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">b</span></a> countries.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a></p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib0035" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mpox – formerly monkey pox – in dermatology: a review of epidemiologic features, clinical presentation, diagnosis, and treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Català" 1 => "J. Riera" 2 => "I. Fuertes" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2023.01.002" "Revista" => array:5 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2023" "volumen" => "114" "paginaInicial" => "318" "paginaFinal" => "326" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0040" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.V. Marzano" 1 => "G. Genovese" 2 => "G. Fabbrocini" 3 => "P. Pigatto" 4 => "G. Monfrecola" 5 => "B.M. Piraccini" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2020.04.044" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2020" "volumen" => "83" "paginaInicial" => "280" "paginaFinal" => "285" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32305439" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0045" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Do not neglect the covid-19 transmission through sexual intercourse" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S. Abdollahpour" 1 => "S. Badiee Aval" 2 => "T. Khadivzadeh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/0092623X.2021" "Revista" => array:6 [ "tituloSerie" => "J Sex Marital Ther" "fecha" => "2021" "volumen" => "47" "paginaInicial" => "731" "paginaFinal" => "737" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34346289" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0050" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Monkeypox" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M. Moore" 1 => "F. Zahra" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:4 [ "titulo" => "StatPearls" "fecha" => "2022" "editorial" => "StatPearls Publishing" "editorialLocalizacion" => "Treasure Island (FL)" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0055" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical features and management of human monkeypox: a retrospective observational study in the UK" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "NHS England High Consequence Infectious Diseases (Airborne) Network" "etal" => true "autores" => array:6 [ 0 => "H. Adler" 1 => "S. Gould" 2 => "P. Hine" 3 => "L.B. Snell" 4 => "W. Wong" 5 => "C.F. Houlihan" ] ] ] ] ] "host" => array:2 [ 0 => array:2 [ "doi" => "10.1016/S1473-3099(22)00228-6" "Revista" => array:6 [ "tituloSerie" => "Lancet Infect Dis" "fecha" => "2022" "volumen" => "22" "paginaInicial" => "1153" "paginaFinal" => "1162" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/35623380" "web" => "Medline" ] ] ] ] 1 => array:2 [ "doi" => "10.1016/S1473-3099(22)00228-6" "WWW" => array:1 [ "link" => "https://doi.org/10.1016/S1473-3099(22)00228-6" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0060" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevention of monkeypox with vaccines: a rapid review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G.A. Poland" 1 => "R.B. Kennedy" 2 => "P.K. Tosh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1473-3099(22)00574-6" "Revista" => array:4 [ "tituloSerie" => "Lancet Infect Dis" "fecha" => "2022" "paginaInicial" => "e349" "paginaFinal" => "e358" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00017310/unassign/S0001731024007208/v1_202410080946/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/00017310/unassign/S0001731024007208/v1_202410080946/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731024007208?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 13 | 21 | 34 |
2024 Octubre | 181 | 63 | 244 |
2024 Septiembre | 50 | 66 | 116 |